在心力衰竭中低血症的评估和管理
Giulio M Mondellini1,2, Frederik H Verbrugge3,4
1Division of Cardiology, Department of Health Sciences, San Paolo Hospital, University of Milan, Milan, Italy.
Current heart failure reports
|February 27, 2024
概括
心力衰竭 (HF) 中的低血症源于电解质损失和脏水分泌受损. 治疗重点是管理高血压,补充电解质,并使用利尿剂来改善液体平衡.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 内部医学 内部医学
背景情况:
- 低血是心力衰竭 (HF) 的常见并发症.
- 电解质失衡,特别是和耗尽,导致HF患者的低血症.
- 在HF中,功能障碍会损害脏分泌自由水的能力.
研究的目的:
- 介绍心力衰竭中低血症的当前审查.
- 讨论高频率低血症的病理生理学,诊断评估和治疗策略.
主要方法:
- 文献综述侧重于病理生理学,评估和治疗高频率低血症.
- 对HF患者的电解质障碍和功能最近发现的分析.
主要成果:
- 在HF中低血症与细胞内转移与和损失有关.
- 脏血液动力学和管状功能受损会影响无电解质的水分泌.
- 治疗包括解决潜在的HF,优化血液动力学和管理拥堵.
结论:
- 在HF中,低血症主要是水分泌受损的疾病.
- 补充和是很重要的,但对HF管理来说是次要的.
- 针对近接管道的利尿剂,如SGLT2抑制剂,乙胺和循环利尿剂,最好用于解.
相关概念视频
Heart Failure Drugs: Diuretics
381
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
381
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Heart Failure Drugs: Inotropic Agents
588
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
588
Heart Failure Drugs: β-Blockers
340
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
340
Regulation of Sodium and Potassium
534
The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
534
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K


